doi: 10.1002/ana.10279.
Novel antibodies to synuclein show abundant striatal pathology in Lewy body diseases
Affiliations
- PMID: 12210791
- DOI: 10.1002/ana.10279
Item in Clipboard
Novel antibodies to synuclein show abundant striatal pathology in Lewy body diseases
Ann Neurol.
2002 Aug.
Abstract
Intracytoplasmic inclusions composed of alpha-synuclein (alpha-syn) are characteristic of neurodegenerative Lewy body disorders. Using novel monoclonal antibodies raised against altered alpha-syn, we uncovered an unprecedented and extensive burden of alpha-syn pathology in the striatum of Lewy body disorders. The highest density of striatal pathology was observed in patients with a combination of Alzheimer's disease and dementia with Lewy bodies or pure dementia with Lewy bodies, and these alpha-syn aggregates may contribute to the parkinsonism seen in these disorders.
Similar articles
-
Neuropathological spectrum of synucleinopathies.Mov Disord. 2003 Sep;18 Suppl 6:S2-12. doi: 10.1002/mds.10557. Mov Disord. 2003. PMID: 14502650 Review.
-
Neuropathology of Parkinson's disease dementia and dementia with Lewy bodies with reference to striatal pathology.Parkinsonism Relat Disord. 2007;13 Suppl 3:S221-4. doi: 10.1016/S1353-8020(08)70005-1. Parkinsonism Relat Disord. 2007. PMID: 18267239
-
A mutant PSEN1 causes dementia with Lewy bodies and variant Alzheimer's disease.Ann Neurol. 2005 Mar;57(3):429-34. doi: 10.1002/ana.20393. Ann Neurol. 2005. PMID: 15732120
-
In vitro characterisation of BF227 binding to alpha-synuclein/Lewy bodies.Eur J Pharmacol. 2009 Sep 1;617(1-3):54-8. doi: 10.1016/j.ejphar.2009.06.042. Epub 2009 Jul 1. Eur J Pharmacol. 2009. PMID: 19576880
-
Alpha-synuclein, Abeta and Alzheimer's disease.Prog Neuropsychopharmacol Biol Psychiatry. 2003 Feb;27(1):103-8. doi: 10.1016/S0278-5846(02)00339-1. Prog Neuropsychopharmacol Biol Psychiatry. 2003. PMID: 12551731 Review.
Cited by
-
Association between serum IGF‑1 levels and non-motor symptoms in Parkinson's disease.Neurol Sci. 2025 Mar;46(3):1201-1206. doi: 10.1007/s10072-024-07835-8. Epub 2024 Oct 29. Neurol Sci. 2025. PMID: 39467934
-
Amyloid-β deposition and regional grey matter atrophy rates in dementia with Lewy bodies.Brain. 2016 Oct;139(Pt 10):2740-2750. doi: 10.1093/brain/aww193. Epub 2016 Jul 24. Brain. 2016. PMID: 27452602 Free PMC article.
-
Studies of lipopolysaccharide effects on the induction of α-synuclein pathology by exogenous fibrils in transgenic mice.Mol Neurodegener. 2015 Jul 30;10:32. doi: 10.1186/s13024-015-0029-4. Mol Neurodegener. 2015. PMID: 26223783 Free PMC article.
-
α-Syn suppression reverses synaptic and memory defects in a mouse model of dementia with Lewy bodies.J Neurosci. 2011 Jul 6;31(27):10076-87. doi: 10.1523/JNEUROSCI.0618-11.2011. J Neurosci. 2011. PMID: 21734300 Free PMC article.
-
Α-synuclein immunotherapy blocks uptake and templated propagation of misfolded α-synuclein and neurodegeneration.Cell Rep. 2014 Jun 26;7(6):2054-65. doi: 10.1016/j.celrep.2014.05.033. Epub 2014 Jun 12. Cell Rep. 2014. PMID: 24931606 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
